(CIDRAP News) This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.
WHO's novel H1N1 flu case count tops 4,500The global number of people infected with the novel H1N1 influenza (swine flu) virus rose to 4,694 from 30 countries, the World Health Organization (WHO) reported today. The count includes 1,626 cases and 48 deaths in Mexico and the 2,532 cases and 3 deaths reported in the United States as of yesterday. Canada has reported 284 cases and one death. [WHO update 25]
(CIDRAP) – Europe's drug regulatory agency today released its final review of a link between narcolepsy and the Pandemrix 2009 H1N1 vaccine, which recommends a labeling change that limits the vaccine's use in children and teens to when protection is needed and seasonal trivalent vaccine isn't available.
(CIDRAP News) A final report from Finnish health officials on the link between the 2009 H1N1 Pandemrix vaccine and narcolepsy confirmed the link, finding a greater risk than their earlier estimate and identifying a genetic risk factor in all patients.